{
    "2020-04-29": [
        [
            {
                "time": "",
                "original_text": "华熙生物：业绩稳定增长，成本壁垒加深，全产业链布局",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "业绩增长",
                        "成本壁垒",
                        "全产业链"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "三大主业全面增长 华熙生物披露上市以来首份年报",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "年报",
                        "主业增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "玻尿酸第一股华熙生物：去年销售费用5亿暴增84%，一季度扣非净利润下滑超1成 盈利能力下降",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "销售费用",
                        "净利润下滑",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华熙生物发布2019年度报告 三大主业全面增长稳居行业龙头",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "年度报告",
                        "主业增长",
                        "行业龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}